-+ 0.00%
-+ 0.00%
-+ 0.00%

Aptose Biosciences Reports Safety and Efficacy Results for Tuspetinib Combination in Newly Diagnosed AML

Reuters·12/06/2025 13:13:04

Please log in to view news